ஜெனிபர் சில்வா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SentiAR, a pioneer in visualization technology for interventional procedures, has closed an oversubscribed $5.1 million Series A financing, which will allow the company to accelerate innovation on its groundbreaking mixed reality SentiAR is revolutionizing cardiac surgery and other interventional procedures by providing physicians with holographic visualization through mixed reality. The FDA 510(k) cleared CommandEP™ system is the first guidance system of this type to be used during invasive cardiac procedures. SentiAR CEO, Berk Tas TechWald Holding joined the round as the company s newest investor, supporting SentiAR financially and operationally. Other investors in the Series A funding include BioGenerator (the investment arm of BioSTL), Cultivation Capital, VCapital, Neue Fund, QRM Capital, and Keiretsu Forum.

Berk tasShlomo shpunOperational holding companyKeiretsu forumTechwald teamNeue fundTechwald holding spaTechwald holdingSentiar incWashington university in stCultivation capitalChief scientific officerTechwald partnerWashington universityJennifer silvaAssociate professor